INDIA’S GLOBAL LEADERSHIP IN US-FDA APPROVALS: 2018 – 19 UPDATE
The stringent regulations from international regulatory authorities of US and EU are tightening the noose around the Indian pharma industry. The increasing inspections are driven by rising violations in the manufacturing process. The main reason for being hauled up by a regulatory authority is the high level of risk assessment for each identified hazard. In…